Nagoya Journal of Medical Science

The Nagoya Journal of Medical Science (NJMS) is a general medical journal published by the Nagoya University Graduate School of Medicine. NJMS is dedicated to advancing medical knowledge by publishing original research articles that demonstrate long-term scientific value. The journal maintains a strong editorial stance against commercialism and short-term trends, ensuring that all submissions are evaluated solely on their academic merit.
NJMS accepts articles in all areas of medical science and its related disciplines, including basic biomedical research, clinical medicine, public health, medical education, and interdisciplinary approaches that bridge medicine with other scientific fields. The journal welcomes submissions from researchers affiliated with any institution, both domestic and international.

• 1.NJMS publishes original research papers in the areas of medical science and its related fields. (1) Invited Reviews, (2) Reviews, (3) Original Papers, (4) Case Reports, (5) Short Communications, (6) Hypothesis Papers, (7) Medical Image at a Glance are accepted. Protocol papers are not eligible for publication. For submissions such as symposium reports, notes, or announcements, authors must contact the editorial office in advance.
• 2.Manuscripts should be in English. An English check of the manuscript by a competent and knowledgeable native speaker should be completed before submission.
• 3.By submitting your paper, you certify that your paper is not being simultaneously considered by other journals and that any portion of your current paper has not been previously published in any journal in any language by you or your collaborators except for meeting abstracts or short proceedings. If you have any questions regarding this matter, please contact the editorial office prior to submission. All manuscripts are subject to peer review, and final decisions are made by the Editorial Board.
• 4.Upon acceptance of an article, including invited reviews, for publication, the copyright of the article shall be exclusively assigned to the Journal. To reproduce the article in part or in any form, the author(s) must obtain permission from the Editorial Board.
• 5.Generative AI technologies (hereinafter referred to as “AI”) may be utilized solely as auxiliary tools to support the writing process. The author retains full responsibility for the accuracy and integrity of the content, and must make all final decisions regarding its validation and verification. Any use of AI must be transparently disclosed in appropriate sections such as the methodology or acknowledgments. In cases where AI has contributed to the development of the discussion or conclusions, a detailed account of its influence is required. AI systems must not be listed as authors under any circumstances.

• 1.All manuscripts must be submitted via the electronic submission system ScholarOne Manuscript^TM. Authors are required to prepare separate electronic files, including title page, text, tables and figures, and upload them accordingly.
  A cover letter addressed to the Editor-in-Chief must be included in the designated field or uploaded as a file. The letter should summarize the key points of the manuscript and specify the submission category.
  Authors must also attach the designated Copyright Transfer Agreements and Conflict of Interest (COI) Disclosure Form.
  

  Submission system: https://mc.manuscriptcentral.com/njms
  Note: Prior account registration is required.

• 2.In cases of suspected scientific misconduct (fabrication, falsification of data, double publication, duplicate submission, or plagiarism), the journal will conduct a preliminary investigation. If scientific misconduct is confirmed, the journal may notify the corresponding author’s institution and the funding agencies.
• 3.Manuscripts submitted for publication must contain a statement to the effect that all human studies have been approved by the appropriate ethics committee and have been conducted in accordance with the ethical standards set forth in the Declaration of Helsinki (adopted in 1964, amended in 2024) or in accordance with comparable ethical standards. Animal experiments should be approved by the appropriate animal experimental committee, which has to be described on the paper.

• 1.The manuscript must consist of the following components. Items D and E must be prepared as separate files from the main text.
  A. Title page
  B. Abstract
  C. Text (including main body, acknowledgements, references, and figure legends)
  D. Tables (if any)
  E. Figures (if any)
• 2.How to prepare individual items in your submission package
  Manuscripts must conform to the guidelines of the NJMS. Except for tables, all text should be typed in 12-point Times New Roman font and double-spaced. For grammatical and stylistic conventions, refer to AMA Manual of Style, 11th edition.

A. Title Page

In title page, provide the following information:

(1) Title of your paper
Title should be concise as well as informative and should include the main conclusion of your paper with key words. Abbreviations should not be used.

(2) Running title (i.e., short title) of your paper
Running title must not exceed 40 characters, including spaces.

(3) Full names and affiliations of all authors

(4) Corresponding author information
Include the full name, degree (eg, MD, PhD), affiliation, and contact information (eg, postal code, mailing address, phone number, and email address)
Corresponding author(s) should hold MD (or comparable level of professional certification) and/or PhD, and institutional email addresses for them are recommended to show as contact information.

B. Abstract

The following must be entered into the electronic submission system:

(1) Abstract (unstructured style)
Prepare an unstructured abstract (that is, a paragraph that does not rely on headings such as Methods, Results, and Discussion). The abstract must not exceed 250 words.

(2) Keywords (up to five)

C. Text

Put both page and line numbers. The main text consists of the following parts, and they must appear in the order listed below.

(1) Title


(2) Text (ie, body of your paper)
The manuscript should be organized into the following sections:
Introduction, Materials and Methods, Results, Discussion, Acknowledgments/Conflict of Interest/Funding.
The text of your paper, excluding references, should not exceed 4,000 words. Expand all abbreviations at first mention in the text, and put the abbreviation in parentheses. Do not insert tables or figures into the text of your paper. Instead, indicate where tables and figures are supposed to appear by writing [Table 1], [Fig. 1], and so forth after the paragraph that mentions them for the first time.
You may use up to three levels of headings. Place primary headings at the center of the page in bold type and in capital letters (eg INRODUCTION, MATERIALS AND METHODS, RESULTS, and so forth). Secondary headings are flush left, in italic type, and capitalized sentence style. Tertiary headings are run in at the beginning of a paragraph, in bold type, capitalized sentence style, and followed by a period.
Do not italicize common Latin words such as etc, et al, vs as well, and may not put periods.
SI or SI derived units should be used.

(3) Acknowledgements (author contributions, financial disclosure, previous presentations, miscellaneous acknowledgements, additional contributions)
All authors should declare any financial support or relationship that may pose conflict of interest in Acknowledgement section.

(4) References
The NJMS follows the citation and reference style of the Journal of the American Medical Association (JAMA). Format citations and references according to JAMA’s current style. Consult AMA Manual of Style: A Guide for Authors and Editors, 11th Edition (2020), and papers from the latest issue of JAMA.

JAMA's instructions for authors can be found at:
https://jamanetwork.com/journals/jama/pages/instructions-for-authors#SecReferences

Online edition of AMA Manual of Style (subscription required) can be found at:
http://www.amamanualofstyle.com/

Concise summaries of JAMA's citation and reference style can be found at:
http://guides.lib.uw.edu/c.php?g=99161&p=642281

All manuscripts with a digital object identifier (DOI) must be cited with their DOI.
List all authors up to 6; if 7 or more, list the first 3 followed by "et al."
An accessed date is required if you are citing a web page.

Example:

• Articles
• ・Nakanishi K, Tanaka C, Kanda M, et al. Protocol of a phase II study investigating the efficacy and safety of trifluridine/tipiracil plus ramucirumab as a third-line or later treatment for advanced gastric cancer. Nagoya J Med Sci. 2024;86(1):43-51.doi: 10.18999/nagjms.86.1.43
• ・Morrison G, Van Langenberg DR, Gibson SJ, Gibson PR. Chronic pain in inflammatory bowel disease: characteristics and associations of a hospital-based cohort. Inflamm Bowel Dis. 2013;19(6):1210-1217. doi:10.1097/MIB.0b013e318280e729
• Books
• ・Bickley LS. Bates' Guide to Physical Examination and History Taking. Wolters Kluwer Health/Lippincott WIlliams & Wilkins; 2013.
• ・Lunney JR, Foley KM, Smith TJ, Gelband H, eds. Describing Death in America: What We Need to Know. National Cancer Policy Board, Institute of Medicine; 2003. Accessed March 5, 2019. https://www.nap.edu/read/10619/chapter/1
• ・Kasuya H. The Potential of Oncolytic Virus Therapy for Pancreatic Cancer. In: Yamaue H, ed. Innovation of Diagnosis and Treatment for Pancreatic Cancer. Springer;2017:Chapter 18.
• Web Sites
• ・World Health Organization. Philippines: Assistance and response after Typhoon Haiyan. World Health Organization. November 2013. Accessed March 1, 2019.
  http://www.who.int/features/2013/philippines-typhoon-haiyan/en/index.html

(5) Figure legends
Provide a brief and informative title that identifies the specific figure or what the data show. Figure legends which are concise explanations appear below each figure at the publication, but have to be submitted within the text file. If abbreviations are used in the figure, list them at the end of the legends. Annotations to the figure may appear as footnotes below abbreviations. Place a superscript lowercase letter before each footnote. But if the information conveyed by footnotes can be incorporated into figure legends, do so, instead of using footnotes. Name figures sequentially so that there will be Fig. 1, Fig. 2, Fig. 3, and so forth in a single file.
For composite figures with 2 or more panels, provide a concise and informative title that identifies the entire figure, followed by names of each part (eg, Fig 1A, Fig. 1B) and a description of each.

D. Tables

All tables must be assembled into a single electronic file. Each table must be placed on a separate page. Use 10-point Times New Roman font and single-space text. Do not add vertical lines as well as shading cells for legibility. Provide an informative title for each table. The table title appears above the table. If abbreviations are used in the table, list them below it. Annotations to the table appear as footnotes below abbreviations. Place a superscript lowercase letter before each footnote. Name tables sequentially so that there will be Table 1, Table 2, Table 3, and so forth in a single file.

E. Figures

Figures must be submitted as a separate electronic file.
Name figures sequentially so that there will be Fig. 1, Fig. 2, Fig. 3, and so forth in a single file.